This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

11 Feb 2011

Capsugel Acquires GSK’s Drug Delivery Technology

Capsugel, an innovator in drug delivery systems, announced its acquisition of a novel dosage form developed by GSK.

Capsugel, the world's leading hard capsule manufacturer, has acquired a dosage form developed by GlaxoSmithKline. The technology called FlexTab uses injection molding processes to produce unique capsule-shaped dosage forms that offer a new platform for formulating a wide range of new products.


The FlexTab technology allows for a variety of fill materials, including powders, pellets, liquids, micro-tablets and tablets, and can deliver separate liquid and powder API's in one dose, allowing for new product designs and customization options.

“Capsugel is very excited to have this innovative technology as part of our suite of offerings,” said Keith Hutchison, vice president of R&D at Capsugel. “We believe that the FlexTab technology's uni

Related News